101.7 FM IN GENEVA DAB+, CABLE & SATELLITE ACROSS SWITZERLAND
Total comments: 1 | Add to the discussion.
It is urgent to publish a serious economical analysis of this disaster. What are the reasons and their weights: cultural differences (biotech vs. chemical; Merck vs. Serono), Tax levels, Serono lacks of innovation, competition between two centers Geneva and Darmstadt, Merck’s owners pressure to keep 70% of capital. Also, It seems that Merck will still gain money with Rebif, so this operation is profitable. We wonder about real reasons.